Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Clinical trial NCT01328379 · COMPLETED
Trial details
- NCT number
- NCT01328379
- Sponsor
- Acorda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-04-01
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.